{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:58:49Z","timestamp":1794013129282,"version":"4.8.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T00:00:00Z","timestamp":1468022400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s12020-016-0999-1","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T08:12:54Z","timestamp":1468051974000},"page":"348-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D3 to improve early diabetic nephropathy via the DDIT4\/TSC2\/mTOR pathway"],"prefix":"10.1007","volume":"54","author":[{"given":"Hang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolan","family":"ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zesong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huacong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,9]]},"reference":[{"key":"999_CR1","unstructured":"U. Krairittichai, S. Potisat, A. Jongsareejit, C. Sattaputh, Prevalence and risk factors of diabetic nephropathy among Thai patients with type 2 diabetes mellitus. J. Med. Assoc. Thai. 94 (2011)"},{"key":"999_CR2","doi-asserted-by":"crossref","unstructured":"F.P. Schena, L. Gesualdo, Pathogenetic mechanisms of diabetic nephropathy. J. Am. Soc. Nephrol. 16 (2005)","DOI":"10.1681\/ASN.2004110970"},{"key":"999_CR3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2337\/diab.38.9.1077","volume":"38","author":"MW Steffes","year":"1989","unstructured":"M.W. Steffes, R. \u00d8sterby, B. Chavers, S.M. Mauer, Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38, 1077\u20131081 (1989)","journal-title":"Diabetes"},{"issue":"4","key":"999_CR4","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jc.2007-1817","volume":"93","author":"SY Goh","year":"2008","unstructured":"S.Y. Goh, M.E. Cooper, Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab. 93(4), 1143 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"999_CR5","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/j.1523-1755.2004.66004.x","volume":"66","author":"K Fukami","year":"2004","unstructured":"K. Fukami, S. Ueda, S. Yamagishi, S. Kato, Y. Inagaki, M. Takeuchi, Y. Motomiya, R. Bucala, S. Iida, K. Tamaki, T. Imaizumi, M.E. Cooper, S. Okuda, AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction. Kidney Int. 66(6), 2137\u20132147 (2004)","journal-title":"Kidney Int."},{"key":"999_CR6","first-page":"29","volume":"8","author":"R Yacoub","year":"2015","unstructured":"R. Yacoub, K.N. Campbell, Inhibition of RAS in diabetic nephropathy. Int. J. Nephrol. Renovasc. Dis. 8, 29\u201340 (2015)","journal-title":"J. Nephrol. Renovasc. Dis."},{"issue":"6","key":"999_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2014.74","volume":"10","author":"B Fernandez-Fernandez","year":"2014","unstructured":"B. Fernandez-Fernandez, A. Ortiz, C. Gomez-Guerrero, J. Egido, Therapeutic approaches to diabetic nephropathy\u2013beyond the RAS. Nat. Rev. Nephrol. 10(6), 325\u2013346 (2014)","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"999_CR8","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1046\/j.1523-1755.1999.00438.x","volume":"55","author":"K Inoki","year":"1999","unstructured":"K. Inoki, M. Haneda, S. Maeda, D. Koya, R. Kikkawa, TGF-\u03b21 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. Kidney Int. 55(5), 1704\u20131712 (1999)","journal-title":"Kidney Int."},{"issue":"6","key":"999_CR9","first-page":"2095","volume":"149","author":"S Paolo Di","year":"1996","unstructured":"S. Di Paolo, L. Gesualdo, E. Ranieri, G. Grandaliano, F.P. Schena, High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. Am. J. Pathol. 149(6), 2095\u20132106 (1996)","journal-title":"Am. J. Pathol."},{"key":"999_CR10","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1097\/01.ASN.0000078022.77369.EB","volume":"14","author":"SB Connolly","year":"2003","unstructured":"S.B. Connolly, D. Sadlier, N.E. Kieran, P. Doran, H.R. Brady, Transcriptome profiling and the pathogenesis of diabetic complications. J. Am. Soc. Nephrol. 14, S279\u2013S283 (2003)","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"999_CR11","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2337\/db08-0057","volume":"57","author":"JM Forbes","year":"2008","unstructured":"J.M. Forbes, M.T. Coughlan, M.E. Cooper, Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57(6), 1446\u20131454 (2008)","journal-title":"Diabetes"},{"issue":"8","key":"999_CR12","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/diabetes.54.8.2328","volume":"54","author":"Z Wang","year":"2005","unstructured":"Z. Wang, T. Jiang, J. Li, G. Proctor, J.L. McManaman, S. Lucia, S. Chua, M. Levi, Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb\/db mice with type 2 diabetes. Diabetes 54(8), 2328\u20132335 (2005)","journal-title":"Diabetes"},{"issue":"8","key":"999_CR13","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2337\/diacare.17.8.906","volume":"17","author":"D Dubois","year":"1994","unstructured":"D. Dubois, P. Chanson, J. Timsit, D. Chauveau, D. Nochy, P.J. Guillausseau, J. Lubetzki, Remission of proteinuria following correction of hyperlipidemia in NIDDM patients with nondiabetic glomerulopathy. Diabetes Care 17(8), 906\u2013908 (1994)","journal-title":"Diabetes Care"},{"issue":"20","key":"999_CR14","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.4161\/cc.10.20.17686","volume":"10","author":"MK Lu","year":"2011","unstructured":"M.K. Lu, X.G. Gong, K.L. Guan, mTOR in podocyte function: is rapamycin good for diabetic nephropathy?. Cell Cycle 10(20), 3415\u20133416 (2011)","journal-title":"Cell Cycle"},{"issue":"2","key":"999_CR15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1523-1755.2005.00433.x","volume":"68","author":"K Nagai","year":"2005","unstructured":"K. Nagai, T. Matsubara, A. Mima, E. Sumi, H. Kanamori, N. Iehara, A. Fukatsu, M. Yanagita, T. Nakano, Y. Ishimoto, T. Kita, T. Doi, H. Arai, Gas6 induces Akt\/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int. 68(2), 552\u2013561 (2005)","journal-title":"Kidney Int."},{"issue":"1","key":"999_CR16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","volume":"12","author":"R Zoncu","year":"2011","unstructured":"R. Zoncu, A. Efeyan, D.M. Sabatini, mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12(1), 21\u201335 (2011)","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"999_CR17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bbrc.2009.04.136","volume":"384","author":"H Mori","year":"2009","unstructured":"H. Mori, K. Inoki, K. Masutani, Y. Wakabayashi, K. Komai, R. Nakagawa, K.L. Guan, A. Yoshimura, The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem. Biophys. Res. Commun. 384(4), 471\u2013475 (2009)","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"999_CR18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1755-5922.2010.00206.x","volume":"29","author":"A Eisenreich","year":"2011","unstructured":"A. Eisenreich, U. Rauch, PI3K inhibitors in cardiovascular disease. Cardiovasc. Ther. 29(1), 29\u201336 (2011)","journal-title":"Cardiovasc. Ther."},{"issue":"12","key":"999_CR19","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1681\/ASN.2008111186","volume":"20","author":"W Lieberthal","year":"2009","unstructured":"W. Lieberthal, J.S. Levine, The role of the mammalian target of rapamycin (mTOR) in renal disease. J. Am. Soc. Nephrol. 20(12), 2493\u20132502 (2009)","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"999_CR20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000106782","volume":"27","author":"Y Yang","year":"2007","unstructured":"Y. Yang, J. Wang, L. Qin, Z. Shou, J. Zhao, H. Wang, Y. Chen, J. Chen, Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am. J. Nephrol. 27(5), 495\u2013502 (2007)","journal-title":"Am. J. Nephrol."},{"key":"999_CR21","doi-asserted-by":"crossref","unstructured":"S. Langer, R. Kreutz, A. Eisenreich, Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions. J. Nephrol. (2016) [Epub ahead of print 5 Jan]","DOI":"10.1007\/s40620-015-0258-1"},{"issue":"4","key":"999_CR22","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/db07-0922","volume":"57","author":"M Fraenkel","year":"2008","unstructured":"M. Fraenkel, M. Ketzinel-Gilad, Y. Ariav, O. Pappo, M. Karaca, J. Castel, M.F. Berthault, C. Magnan, E. Cerasi, N. Kaiser, G. Leibowitz, mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolicstate in type 2 diabetes. Diabetes 57(4), 945\u2013957 (2008)","journal-title":"Diabetes"},{"issue":"4","key":"999_CR23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nut.2010.07.022","volume":"27","author":"MC Borges","year":"2011","unstructured":"M.C. Borges, L.A. Martini, M.M. Rogero, Current perspectives on vitamin D, immune system, and chronic diseases. Nutrition 27(4), 399\u2013404 (2011)","journal-title":"Nutrition"},{"issue":"3","key":"999_CR24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1096\/fj.10-172577","volume":"25","author":"TS Lisse","year":"2011","unstructured":"T.S. Lisse, T. Liu, M. Irmler, J. Beckers, H. Chen, J.S. Adams, M. Hewison, Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTORsignaling. FASEB J. 25(3), 937\u2013947 (2011)","journal-title":"FASEB J."},{"issue":"12","key":"999_CR25","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.4161\/cc.10.12.15620","volume":"10","author":"TS Lisse","year":"2011","unstructured":"T.S. Lisse, M. Hewison, Vitamin D: a new player in the world of mTOR signaling. Cell Cycle 10(12), 1888\u20131889 (2011)","journal-title":"Cell Cycle"},{"issue":"5","key":"999_CR26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3122\/jabfm.2009.05.080231","volume":"22","author":"VA Diaz","year":"2009","unstructured":"V.A. Diaz, A.G. Mainous 3rd, P.J. Carek, A.M. Wessell, C.J. Everett, The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for healthdisparities. J. Am. Board Fam. Med. 22(5), 521\u2013527 (2009)","journal-title":"J. Am. Board Fam. Med."},{"issue":"2","key":"999_CR27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5301\/JN.2011.8429","volume":"25","author":"A Levin","year":"2012","unstructured":"A. Levin, M. Le Barbier, L. Er, D. Andress, M.K. Sigrist, O. Djurdjev, Incident isolated 1,25(OH)(2)D(3) deficiency is more common than 25(OH)D deficiency in CKD. J. Nephrol. 25(2), 204\u2013210 (2012)","journal-title":"J. Nephrol."},{"issue":"1","key":"999_CR28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jcp.22186","volume":"225","author":"Nirmalya Dey","year":"2010","unstructured":"Nirmalya Dey, Nandini Ghosh-Choudhury, Falguni Das, Xiaonan Li, Balachandar Venkatesan, Jeffrey L. Barnes, Balakuntalam S. Kasinath, Goutam Ghosh Choudhury, PRAS40 acts as a nodal regulator of high glucose-induced TORC1 activation in glomerular mesangial cell hypertrophy. J. Cell Physiol. 225(1), 27\u201341 (2010)","journal-title":"J. Cell Physiol."},{"issue":"9","key":"999_CR29","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.phymed.2004.01.014","volume":"12","author":"SI Jeong","year":"2005","unstructured":"S.I. Jeong, D.H. Kwak, S. Lee, Y.K. Choo, W.H. Woo, K.S. Keum, B.K. Choi, K.Y. Jung, Inhibitory effects of Cnidium officinale Makino and Tabanus fulvus Meigan on the high glucose-induced proliferation of glomerular mesangial cells. Phytomedicine 12(9), 648\u2013655 (2005)","journal-title":"Phytomedicine"},{"issue":"2)","key":"999_CR30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1523-1755.2005.00433.x","volume":"68","author":"Kojiro Nagai","year":"2005","unstructured":"Kojiro Nagai, Takeshi Matsubara, Akira Mima, Eriko Sumi, Hiroshi Kanamori et al. Gas6 induces Akt\/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int 68(2), 552\u2013561 (2005)","journal-title":"Kidney Int"},{"issue":"2","key":"999_CR31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijcard.2014.02.041","volume":"173","author":"TW Lee","year":"2014","unstructured":"T.W. Lee, Y.H. Kao, T.I. Lee, C.J. Chang, G.S. Lien, Y.J. Chen, Calcitriol modulates receptor for advanced glycation end products (RAGE) in diabetic hearts. Int. J. Cardiol. 173(2), 236\u2013241 (2014)","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"999_CR32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/db09-1218","volume":"59","author":"GY Oudit","year":"2010","unstructured":"G.Y. Oudit, G.C. Liu, J. Zhong, R. Basu, F.L. Chow, J. Zhou, H. Loibner, E. Janzek, M. Schuster, J.M. Penninger, A.M. Herzenberg, Z. Kassiri, J.W. Scholey, Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 59(2), 529\u2013538 (2010)","journal-title":"Diabetes"},{"issue":"4","key":"999_CR33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2220\/biomedres.35.227","volume":"35","author":"S Okada","year":"2014","unstructured":"S. Okada, S. Inaga, Y. Kawaba, T. Hanada, A. Hayashi, H. Nakane, T. Naguro, T. Kaidoh, S. Kanzaki, A novel approach to the histological diagnosis of pediatric nephrotic syndrome by low vacuum scanning electronmicroscopy. Biomed. Res. 35(4), 227\u2013236 (2014)","journal-title":"Biomed. Res."},{"issue":"6","key":"999_CR34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1203\/01.pdr.0000245912.78078.d5","volume":"60","author":"D Sankaran","year":"2006","unstructured":"D. Sankaran, N. Bankovic-Calic, C.Y. Peng, M.R. Ogborn, H.M. Aukema, Dietary flax oil during pregnancy and lactation retards disease progression in rat offspring with inherited kidneydisease. Pediatr. Res. 60(6), 729\u2013733 (2006)","journal-title":"Pediatr. Res."},{"key":"999_CR35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1113\/jphysiol.2006.125773","volume":"579","author":"RR Singh","year":"2007","unstructured":"R.R. Singh, L.A. Cullen-McEwen, M.M. Kett, W.M. Boon, J. Dowling, J.F. Bertram, K.M. Moritz, Prenatal corticosterone exposure results in altered AT1\/AT2, nephron deficit and hypertension in the rat offspring. J. Physiol. 579, 503\u2013513 (2007)","journal-title":"J. Physiol."},{"key":"999_CR36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2015.07.023","volume":"414","author":"Z Yang","year":"2015","unstructured":"Z. Yang, F. Liu, H. Qu, H. Wang, X. Xiao, H. Deng, 1, 25(OH)2D3 protects \u03b2 cell against high glucose-induced apoptosis through mTOR suppressing. Mol. Cell Endocrinol. 414, 111\u2013119 (2015)","journal-title":"Mol. Cell Endocrinol."},{"issue":"10","key":"999_CR37","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.nut.2015.04.009","volume":"31","author":"H Derakhshanian","year":"2015","unstructured":"H. Derakhshanian, S. Shab-Bidar, J.R. Speakman, H. Nadimi, K. Djafarian, Vitamin D and diabetic nephropathy: A systematic review and meta-analysis. Nutrition 31(10), 1189\u20131194 (2015)","journal-title":"Nutrition"},{"issue":"5","key":"999_CR38","doi-asserted-by":"crossref","first-page":"F1212","DOI":"10.1152\/ajprenal.00002.2009","volume":"296","author":"DK Deb","year":"2009","unstructured":"D.K. Deb, Y. Chen, Z. Zhang, Y. Zhang, F.L. Szeto, K.E. Wong, J. Kong, Y.C. Li, 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells byblocking the NF-{kappa}B pathway. Am. J. Physiol. Renal. Physiol. 296(5), F1212\u2013F1218 (2009)","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"2","key":"999_CR39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.ki.5002296","volume":"72","author":"Z Zhang","year":"2007","unstructured":"Z. Zhang, W. Yuan, L. Sun, F.L. Szeto, K.E. Wong, X. Li, J. Kong, Y.C. Li, 1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int. 72(2), 193\u2013201 (2007)","journal-title":"Kidney Int."},{"issue":"4","key":"999_CR40","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.133.4.1748","volume":"133","author":"AK Bhalla","year":"1984","unstructured":"A.K. Bhalla, E.P. Amento, B. Serog, L.H. Glimcher, 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J. Immunol. 133(4), 1748\u20131754 (1984)","journal-title":"J. Immunol."},{"issue":"10","key":"999_CR41","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1210\/endo.140.10.7025","volume":"140","author":"M Kajikawa","year":"1999","unstructured":"M. Kajikawa, H. Ishida, S. Fujimoto, E. Mukai, M. Nishimura, J. Fujita, Y. Tsuura, Y. Okamoto, A.W. Norman, Y. Seino, An insulinotropic effect of vitamin D analog with increasing intracellular Ca2+ concentration in pancreatic beta-cells through nongenomic signal transduction. Endocrinology 140(10), 4706\u20134712 (1999)","journal-title":"Endocrinology"},{"issue":"1","key":"999_CR42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2008.08.020","volume":"204","author":"A Cardus","year":"2009","unstructured":"A. Cardus, S. Panizo, M. Encinas, X. Dolcet, C. Gallego, M. Aldea, E. Fernandez, J.M. Valdivielso, 1,25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGFpromoter. Atherosclerosis 204(1), 85\u201389 (2009)","journal-title":"Atherosclerosis"},{"issue":"4","key":"999_CR43","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/path.4593","volume":"237","author":"M Garsen","year":"2015","unstructured":"M. Garsen, R. Sonneveld, A.L. Rops, S. Huntink, T.H. van Kuppevelt, T.J. Rabelink, J.G. Hoenderop, J.H. Berden, T. Nijenhuis, J. van der Vlag, Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte. J. Pathol 237(4), 472\u2013481 (2015)","journal-title":"J. Pathol"},{"issue":"3","key":"999_CR44","doi-asserted-by":"crossref","first-page":"F801","DOI":"10.1152\/ajprenal.00338.2010","volume":"300","author":"XX Wang","year":"2011","unstructured":"X.X. Wang, T. Jiang, Y. Shen, H. Santamaria, N. Solis, C. Arbeeny, M. Levi, Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism. Am. J. Physiol. Renal Physiol. 300(3), F801\u2013F810 (2011)","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"3","key":"999_CR45","doi-asserted-by":"crossref","first-page":"F526","DOI":"10.1152\/ajprenal.00316.2003","volume":"286","author":"A Kuhlmann","year":"2004","unstructured":"A. Kuhlmann, C.S. Haas, M.L. Gross, U. Reulbach, M. Holzinger, U. Schwarz, E. Ritz, K. Amann, 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomizedrat. Am. J. Physiol. Renal Physiol. 286(3), F526\u2013F533 (2004)","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"999_CR46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40618-015-0381-9","volume":"39","author":"F Marampon","year":"2015","unstructured":"F. Marampon, G.L. Gravina, C. Festuccia, V.M. Popov, E.A. Colapietro, P. Sanit\u00e0, D. Musio, F. De Felice, A. Lenzi, E.A. Jannini, E. Di Cesare, V. Tombolini, Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK\/SirT1 axis. J. Endocrinol Invest 39(4), 411\u2013422 (2015)","journal-title":"J. Endocrinol Invest"},{"issue":"3","key":"999_CR47","doi-asserted-by":"crossref","first-page":"F791","DOI":"10.1152\/ajprenal.00247.2009","volume":"297","author":"Y Zhang","year":"2009","unstructured":"Y. Zhang, D.K. Deb, J. Kong, G. Ning, Y. Wang, G. Li, Y. Chen, Z. Zhang, S. Strugnell, Y. Sabbagh, C. Arbeeny, Y.C. Li, Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am. J. Physiol. Renal Physiol. 297(3), F791\u2013F801 (2009)","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"999_CR48","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/db07-0922","volume":"57","author":"M Fraenkel","year":"2008","unstructured":"M. Fraenkel, M. Ketzinel-Gilad, Y. Ariav, O. Pappo, M. Karaca, J. Castel, M.F. Berthault, C. Magnan, E. Cerasi, N. Kaiser, G. Leibowitz, mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 57(4), 945\u2013957 (2008)","journal-title":"Diabetes"},{"issue":"5","key":"999_CR49","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00394-014-0754-4","volume":"54","author":"OA Adegoke","year":"2015","unstructured":"O.A. Adegoke, H.E. Bates, M.A. Kiraly, M. Vranic, M.C. Riddell, E.B. Marliss, Exercise in ZDF rats does not attenuate weight gain, but prevents hyperglycemia concurrent with modulation of amino acid metabolism and AKT\/mTOR activation in skeletal muscle. Eur. J. Nutr. 54(5), 751\u2013759 (2015)","journal-title":"Eur. J. Nutr."},{"issue":"7","key":"999_CR50","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1083\/jcb.201307057","volume":"204","author":"BA Heller","year":"2014","unstructured":"B.A. Heller, M. Ghidinelli, J. Voelkl, S. Einheber, R. Smith, E. Grund, G. Morahan, D. Chandler, L. Kalaydjieva, F. Giancotti, R.H. King, A.N. Fejes-Toth, G. Fejes-Toth, M.L. Feltri, F. Lang, J.L. Salzer, Functionally distinct PI 3-kinase pathways regulate myelination in the peripheral nervous system. J. Cell Biol 204(7), 1219\u20131236 (2014)","journal-title":"J. Cell Biol"},{"issue":"5729","key":"999_CR51","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/281317a0","volume":"281","author":"Y Weisman","year":"1979","unstructured":"Y. Weisman, A. Harell, S. Edelstein, M. David, Z. Spirer, A. Golander, 1 alpha, 25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua andplacenta. Nature 281(5729), 317\u2013319 (1979)","journal-title":"Nature"},{"key":"999_CR52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.nutr.22.120501.150216","volume":"22","author":"JL Omdahl","year":"2002","unstructured":"J.L. Omdahl, H.A. Morris, B.K. May, Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. Annu. Rev. Nutr. 22, 139\u2013166 (2002)","journal-title":"Annu. Rev. Nutr."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0999-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-0999-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0999-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T05:08:14Z","timestamp":1692421694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-0999-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,9]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["999"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-0999-1","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,9]]}}}